Human Health And Disease

Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing.

Pneumonia can be caused by a variety of organisms, including bacteria, viruses, and fungi.

Looking at the specific options provided:

• Streptococcus pneumoniae: This bacterium, also known as pneumococcus, is one of the most common causes of community-acquired bacterial pneumonia in adults and children.
• Haemophilus influenzae: This bacterium (specifically type b, before widespread vaccination, and now more commonly non-typeable strains) is another significant cause of bacterial pneumonia, particularly in young children and adults with underlying health conditions like COPD.

Since both Streptococcus pneumoniae and Haemophilus influenzae are well-established bacterial causes of pneumonia, the correct answer encompasses both.

Therefore, pneumonia can be caused by Both (A) & (B).

Let's analyze the nature and function of α-1 antitrypsin (AAT):

• What it is: α-1 antitrypsin is a protein, specifically a serine protease inhibitor (serpin). It is naturally produced mainly by the liver and circulates in the blood.
• What it does: Its primary role is to protect the body's tissues from being damaged by enzymes released from immune cells, particularly neutrophil elastase. Neutrophil elastase is an enzyme released by neutrophils (a type of white blood cell) during inflammation, and its main function is to break down harmful bacteria. However, if unregulated, it can also break down elastin, a key component of lung tissue elasticity. AAT inhibits neutrophil elastase, thus protecting the lungs.
• Deficiency: Genetic deficiency of α-1 antitrypsin (AATD) leads to insufficient protection of the lungs from neutrophil elastase. This results in progressive damage to the lung alveoli, leading to conditions like emphysema (a type of chronic obstructive pulmonary disease, COPD). It can also cause liver disease due to the accumulation of abnormal AAT protein in liver cells.
• Therapeutic Use: For individuals with severe AATD and related lung disease, augmentation therapy using purified α-1 antitrypsin protein (obtained from human plasma or produced via recombinant DNA technology) is administered intravenously. This therapy aims to increase the levels of AAT in the lungs, providing protection against elastase and slowing the progression of emphysema.

Now let's evaluate the options:

• an antacid: Incorrect. Antacids neutralize stomach acid.
• an enzyme: Incorrect. It is a protease inhibitor, which blocks the activity of enzymes.
• used to treat emphysema: Correct. Specifically, it is used as augmentation therapy for emphysema caused by α-1 antitrypsin deficiency.
• used to treat arthritis: Incorrect. While inflammation is part of arthritis, AAT therapy is specifically targeted for AATD-related lung disease.

Therefore, α-1 antitrypsin is used to treat emphysema (associated with its deficiency).

Particulates of less than 2.5 micrometers in diameter (commonly referred to as PM2.5) pose the greatest risk to human health.

Why PM2.5 is Dangerous:

These fine particles are small enough to be inhaled deeply into the lungs and can even enter the bloodstream.

They can cause or exacerbate respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular diseases.

PM2.5 particles can also carry toxic substances like heavy metals and carcinogens, which increase their harmful effects on health.

Because of their small size and ability to penetrate deep into the body, PM2.5 is a major concern in urban air pollution and is associated with increased mortality rates from cardiovascular and respiratory diseases.